On June 14, 2022, PILMA sent the following letter to USTR Ambassador Tai on the proposed WTO/TRIPS waiver. Download the letter here. Dear Ambassador Tai, The Pharmaceutical Industry Labor-Management Association, which advances the dual goals of fostering innovation of life-saving cures and securing high-quality union construction jobs, continues to be concerned about developments with regard […]
News
PILMA Statement on Drug Importation Legislation
On June 8, 2022, PILMA released the following statement on drug importation legislation and PDUFA. Download the statement here. PILMA has a long history of opposing importation of foreign biopharmaceutical products into the U.S. due to the impact on U.S. construction jobs and patient safety. Congress is considering adding a prescription drug importation provision to […]
PILMA Letter to USTR on WTO TRIPS Waiver
On March 25, 2022, PILMA sent the following letter to U.S. Trade Representative Ambassador Tai on the consequences of eliminating patent protections on biopharmaceuticals. Download the letter here. March 25, 2022 Dear Ambassador Tai, On behalf of the Pharmaceutical Industry Labor-Management Association, which advances the dual goals of fostering innovation of life-saving cures and securing […]
Statement on the Bipartisan Infrastructure Act
Today, PILMA released the following statement applauding the passage of the Bipartisan Infrastructure Act November 6, 2021 Download the full statement here. PILMA commends Congress for passing landmark legislation that will put union men and women to work updating our nation’s infrastructure. This bill will put the safest, best trained, and highest-skilled workers on the […]
USTR Letter: WTO TRIPS
View letter from PILMA Executive Director, Tim Dickson October 22, 2021Katherine TaiUnited States Trade Representative600 17th Street, NWWashington, DC 20508 Dear Ambassador Tai, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA), which advances the dual goals of fostering innovation of life-saving cures and securing high-quality union construction jobs, I write to reiterate concerns we […]
Statement on WTO TRIPS Intellectual Property Waiver
On May 6, 2021, PILMA released the following statement on the far reaching negative impacts of the U.S. signing on to the WTO TRIPS waiver. Download the statement here. May 6, 2021 The U.S. Trade Representative’s decision to support waiving intellectual property protections for the COVID-19 vaccine is a danger to worldwide health and security, […]